๐ Key Learning
-
Generalised anxiety disorder is diagnosed after 6 months of excessive, disproportionate worry with โฅ3 core physical/cognitive symptoms
- GAD-2 or GAD-7 can aid assessment
- Management follows a stepped approach beginning with education and self-help, progressing to CBT and pharmacological treatments (SSRIs - sertraline)
-
Panic disorder involves spontaneous panic attacks with autonomic symptoms and is also managed using CBT or SSRIs (sertraline).
- Beta-blockers (propranolol) can be used for physical symptoms.
- Agoraphobia involves fear of public spaces due to difficulty escaping perceived unsafe environments
๐ Generalised Anxiety Disorder (GAD)
๐ Diagnosis (DSM-5 Criteria)
Symptoms present for at least 6 months:
- Persistent and excessive worry about everyday issues
- Anxiety is disproportionate to actual risk
Plus โฅ3 of the following:
- Restlessness or feeling on edge
- Fatigue
- Poor concentration
- Irritability
- Muscle tension (e.g. neck/shoulders)
- Sleep disturbance or insomnia
๐งช Screening Tools
-
GAD-2 and GAD-7 questionnaires
- Score 0โ3 per item
-
GAD-7 thresholds:
- 5 = mild
- 10 = moderate
- 15 = severe
๐ Management of GAD (NICE CG113)
NICE recommend the following stepwise process in the management of GAD
Step 1: Education and active monitoring
- Psychoeducation
- Lifestyle advice and follow-up
Step 2: Low-intensity psychological interventions
- Non-facilitated individual self-help
- Guided individual self-help
- Psychoeducational group therapy (CBT-based)
Step 3: High-intensity intervention or pharmacological therapy
Offer to those with:
- Significant functional impairment
- Inadequate response to Step 2
Psychological options:
- Individual high-intensity CBT
- Applied relaxation therapy
Pharmacological options:
- 1st line: Sertraline (SSRI)
- 2nd line: alternative SSRI (e.g. escitalopram, paroxetine) or SNRI (e.g. duloxetine, venlafaxine)
- If contraindicated or not tolerated โ consider pregabalin
Note: Continue antidepressants for at least 12 months after improvement to reduce relapse risk
Step 4: Specialist referral
- Refer for psychiatric assessment if above steps fail
๐ฑ Panic Disorder
๐ Clinical Features
Sudden and recurrent panic attacks involving:
- Palpitations, tachycardia
- Nausea, chest pain
- Hyperventilation or breathlessness
- Paraesthesia or dizziness
- Sense of doom or fear of dying
๐ Management (NICE CG113)
Follows a stepped care approach:
Step 1: Recognition and diagnosis
Step 2: Primary care management
-
Mild to moderate:
- Low-intensity interventions (facilitated or self-help CBT-based resources)
-
Moderate to severe:
- CBT or
- SSRI (e.g. sertraline)
Duration:
- Continue antidepressant for at least 6 months after improvement before tapering
๐๏ธ Agoraphobia
Description
- An anxiety disorder which is characterised by an irrational fear of open spaces and crowds.
- Intense anxiety in places where escape might be difficult or help unavailable
- Commonly triggered in crowds, public transport, shopping centres
- May lead to avoidance of leaving home altogether
๐ Exam Clues & Clinchers
- 1st line pharmacological management for severe GAD or panic disorder? โ Sertraline
- Palpitations + hyperventilation + paraesthesia โ panic disorder
- GAD-7 score of 10 โ indicates moderate anxiety
- Avoidance of public places due to fear of entrapment โ agoraphobia
- GAD improved on SSRI โ continue for 12 months
- Panic disorder improved on SSRI โ continue for 6 months
๐ Useful Links and References
NICE CKS: Generalised Anxiety Disorder [2023]. Available at URL: https://cks.nice.org.uk/topics/generalized-anxiety-disorder/
NICE: Generalised Anxiety Disorder and Panic Disorder in Adults [CG113] 2020. Available at URL: https://www.nice.org.uk/guidance/cg113/chapter/Recommendations#principles-of-care-for-people-with-panic-disorder